Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

After 16 weeks of testing, we noticed visible results. Here are our favorite red light therapy devices for hair growth.

Novo Nordisk received approval from the Food and Drug Administration for three new indications of Sogroya, a growth hormone.

When a plant's immune system is triggered, its growth is stunted. Colorado State University researchers have discovered how ...

Peptide therapy has gained popularity as a potential health and longevity booster, but experts are warning of cautions and limitations. Peptides are short chains of amino acids that act as messengers ...

Yet in most cases, doctors cannot identify a clear structural cause, making long-term treatment difficult. A new study published in Volume 14 of the journal Bone Research on January 22, 2026, suggests ...

Novo Nordisk is rated Buy, with the FDA-approved Wegovy pill seen as a potential catalyst to reignite growth and recapture market share. NVO faces headwinds from lower pill pricing, potential ...

NEW YORK, Dec 24 (Reuters) - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become ...

Guggenheim's Seamus Fernandez joins 'Fast Money' to talk Novo Nordisk getting Wegovy pill approved. Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more ...

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.